Loading
CD
Chembio Diagnostics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Perceptive Credit Advisors, LLC, was filed 25 Apr 2023.
Chembio Diagnostics, Inc.: what insiders have been doing
Chembio Diagnostics, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Chembio Diagnostics, Inc. has had no insider filing for more than a year; the last one goes back to 2 May 2023.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
21
Thresholds
n/a
Buy Volume
€222,810
5 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 2 May 2023
Declarations21 total
3,823 shares@ US$0.323.6% of flowCommon StockSEC:0001140361-23-022498:1
10,575 shares@ US$0.4413.0% of flowCommon StockSEC:0001140361-23-022498:3
2,843 shares@ US$0.393.1% of flowCommon StockSEC:0001140361-23-022498:5
66,450 shares@ US$0.4580.3% of flowCommon StockSEC:0001140361-23-022498:6
10,594 sharesCommon StockSEC:0001140361-23-022498:0
29,333 sharesCommon StockSEC:0001140361-23-022498:2
7,885 sharesCommon StockSEC:0001140361-23-022498:4
5,162,782 shares@ US$0.4590.4% of flowCommon StockSEC:0001062993-23-009790:0
4,892 sharesCommon StockSEC:0001140361-23-022236:0
5,734 sharesCommon StockSEC:0001140361-23-022237:0
38,709 sharesCommon StockSEC:0001140361-23-022235:0
16,314 sharesCommon StockSEC:0001140361-23-022234:0
4,101 sharesCommon StockSEC:0001140361-23-022231:0
16,314 sharesCommon StockSEC:0001140361-23-022230:0
53,571 sharesCommon StockSEC:0001140361-23-022238:0
4,940 shares@ US$2.38100.0% of flowCommon StockSEC:0001140361-23-022233:0
70,200 shares@ US$0.4481.2% of flowCommon StockSEC:0000899243-23-011689:0
Canonical exit: 20 Jul 2023 (T+90)
15,800 shares@ US$0.4480.3% of flowCommon StockSEC:0000899243-23-011511:0
Canonical exit: 17 Jul 2023 (T+90)
140,134 shares@ US$0.452.4% of flowCommon StockSEC:0000899243-23-011334:0
Canonical exit: 12 Jul 2023 (T+90)
129,000 shares@ US$0.442.2% of flowCommon StockSEC:0001062993-23-009144:0
Canonical exit: 10 Jul 2023 (T+90)
195,938 shares@ US$0.443.4% of flowCommon StockSEC:0000899243-23-010947:0
Canonical exit: 3 Jul 2023 (T+90)
21 of 21 declarations
About Chembio Diagnostics, Inc.
Chembio Diagnostics, Inc. is a company focused on developing diagnostic tests for infectious diseases. It is listed on the NASDAQ under the symbol CEMI.
